Ledger.Open graph →
SEC Form D · filed June 12, 2020

Mereo Biopharma Group plc

Offering
$70.0M
Sold
$70.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
LONDON, United Kingdom
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Michael Wyzga · Leiden, P7DirectorDr. Peter Fellner · London, United KingdomDirectorRichard Jones · Eugene, ORExec · DirectorKunal Kashyap · London, United KingdomDirectorPaul Blackburn · London, United KingdomDirectorJohn Richard · Fremont, CAExecDr. Denise Scots-Knight · London, United KingdomExec · DirectorJill Henrich · London, United KingdomExecCharles Sermon · London, United KingdomExecPeter Bains · London, United KingdomDirectorDr. Anders Ekblom · London, United KingdomDirectorDr. Deepa Pakianathan · London, United KingdomDirectorDr. Alastair Mackinnon · London, United KingdomExecDr. Peter Fellner · London, United KingdomDirectorRichard Jones · FREDERICTON, New Brunswick, CanadaExec · DirectorKunal Kashyap · London, United KingdomDirectorPaul Blackburn · London, United KingdomDirectorJohn Richard · London, United KingdomExecDr. Denise Scots-Knight · London, United KingdomExec · DirectorJill Henrich · London, United KingdomExecCharles Sermon · London, United KingdomExecPeter Bains · London, United KingdomDirectorMichael Wyzga · Redwood City, CADirectorDr. Anders Ekblom · London, United KingdomDirectorDr. Deepa Pakianathan · London, United KingdomDirectorDr. Alastair Mackinnon · London, United KingdomExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗